Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,468,595 papers from all fields of science
Search
Sign In
Create Free Account
N-caproylsphingosine
Known as:
C(6)-ceramide
, C6-ceramide
, N-Hexanoylsphingosine
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Ceramides
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
HDAC6 and Ovarian Cancer
Joshua Haakenson
,
X. Zhang
International Journal of Molecular Sciences
2013
Corpus ID: 19290823
The special class IIb histone deacetylase, HDAC6, plays a prominent role in many cellular processes related to cancer, including…
Expand
2000
2000
Changes in ceramide and sphingomyelin following fludarabine treatment of human chronic B-cell leukemia cells.
Shyam S. Biswal
,
K. Datta
,
G. Acquaah-Mensah
,
J. Kehrer
Toxicology
2000
Corpus ID: 40037121
1999
1999
Ceramide toxicity and metabolism differ in wild-type and multidrug-resistant cancer cells.
A. Lucci
,
A. Giuliano
,
+4 authors
M. Cabot
International Journal of Oncology
1999
Corpus ID: 26039967
Previously we demonstrated that multidrug-resistant (MDR) cancer cells have elevated levels of a glycosylated form of ceramide…
Expand
Highly Cited
1999
Highly Cited
1999
Induction of Endocytic Vesicles by Exogenous C6-ceramide*
Ruixiang Li
,
E. Blanchette-Mackie
,
S. Ladisch
Journal of Biological Chemistry
1999
Corpus ID: 41281478
Ceramide is a newly discovered second messenger that has been shown to cause cell growth arrest and apoptosis. Here, we present…
Expand
Highly Cited
1998
Highly Cited
1998
Bipotential roles of ceramide in the growth of hippocampal neurons: Promotion of cell survival and dendritic outgrowth in dose‐ and developmental stage–dependent manners
J. Mitoma
,
Makoto Ito
,
S. Furuya
,
Y. Hirabayashi
Journal of Neuroscience Research
1998
Corpus ID: 8580344
Ceramide is now regarded as a lipid messenger molecule involved in a variety of cellular processes, including growth…
Expand
1998
1998
Induction of p21 during ceramide-mediated apoptosis in human hepatocarcinoma cells.
W. Oh
,
Won Ho Kim
,
K. Kang
,
Tae Yun Kim
,
M. Kim
,
Kyunghee Choi
Cancer Letters
1998
Corpus ID: 19171228
Highly Cited
1997
Highly Cited
1997
Alteration of the Sphingomyelin/Ceramide Pathway Is Associated with Resistance of Human Breast Carcinoma MCF7 Cells to Tumor Necrosis Factor-α-mediated Cytotoxicity*
Z. Cai
,
A. Bettaieb
,
+4 authors
S. Chouaib
Journal of Biological Chemistry
1997
Corpus ID: 3048592
The interference of tumor necrosis factor-α (TNF) signaling processes with the acquisition of tumor resistance to TNF was…
Expand
Highly Cited
1997
Highly Cited
1997
Evidence that tumor necrosis factor triggers apoptosis in human endothelial cells by interleukin-1-converting enzyme-like protease-dependent and -independent pathways.
M. Slowik
,
W. Min
,
T. Ardito
,
A. Karsan
,
M. Kashgarian
,
J. Pober
Laboratory investigation; a journal of technical…
1997
Corpus ID: 35273344
Cultured human endothelial cells (EC) resist tumor necrosis factor (TNF)-mediated apoptosis. However, the combination of TNF and…
Expand
Highly Cited
1996
Highly Cited
1996
c-Jun Is a Downstream Target for Ceramide-activated Protein Phosphatase in A431 Cells*
J. Reyes
,
Ignacio Javier González Robayna
,
+5 authors
C. R. D. de Galarreta
Journal of Biological Chemistry
1996
Corpus ID: 7209057
Stimulation of [3H]serine-labeled A431 cells with tumor necrosis factor-α (TNFα) or bacterial sphingomyelinase (SMase) resulted…
Expand
Highly Cited
1995
Highly Cited
1995
Sphingomyelin‐ceramide turnover in CD28 costimulatory signaling
G. Chan
,
A. Ochi
European Journal of Immunology
1995
Corpus ID: 43270987
When the CD28 membrane glycoprotein of T cells binds to its ligand, a signal is transmitted that is required for T cell receptor…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE